lifestyle.ukuncut.org.uk

Author: GH Research PLC

GH Research Announces Pricing of $117.5 Million Underwritten Offering

April 29, 2026
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD

March 25, 2026
GH Research Reports Full Year 2025 Financial Results and Provides Business Update

March 5, 2026